SecBot SecBot
SECBOTREPLAY Home › Report › DAWN

DAWN · Servier has agreed to acquire Day One Biopharmaceuticals (DAWN) for…

Day One Biopharmaceuticals, Inc. · PRESS-RELEASE filed Mar 6, 2026 at 08:30 ET

At the news

BULLISHIMPACT 9/10

PRESS-RELEASE filed Mar 6, 2026 at 08:30 ET

Servier has agreed to acquire Day One Biopharmaceuticals (DAWN) for $21.50 per share in cash, representing a total equity value of approximately $2.5 billion. The offer includes a 68% premium over Day One's closing price on March 5, 2026, and is expected to close in Q2 2026, pending regulatory approval and shareholder tender.

  • Servier is acquiring Day One Biopharmaceuticals for $21.50 per share in cash
  • Total equity value of the transaction is approximately $2.5 billion
  • Offer represents a 68% premium over DAWN's March 5, 2026 closing price and 86% over one-month VWAP
  • Transaction expected to close in Q2 2026, subject to antitrust clearance and shareholder tender

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access